Takeda Pharmaceutical Q2 Adj. EPS $0.48 Beats $0.31 Estimate, Sales $7.457B Beat $7.190B Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsHotEarnings Beats
Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.31 by 54.84 percent. This is a 20 percent increase over earnings of $0.40 per share from
Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.31 by 54.84 percent. This is a 20 percent increase over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $7.457 billion which beat the analyst consensus estimate of $7.190 billion by 3.71 percent. This is a 6.67 percent increase over sales of $6.991 billion the same period last year.